VBI Reports Third Quarter 2014 Financial Results and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
VBI Reports Third Quarter 2014 Financial Results and Provides Update on CMV Vaccine Development

CAMBRIDGE, Mass., Nov. 14, 2014 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq: VBIV ) ("VBI") has filed operational and financial results for the three- and nine-month periods ended September 30 th , 2014 on Form 10-Q with the U.S. Securities and Exchange Commission ("SEC"). The Quarterly Report on Form 10-Q is available on the SEC's website at http://www.sec.gov and on VBI's website at http://ir.vbivaccines.com under "SEC Filings."

"The third quarter was transformative for VBI," said Jeff Baxter, VBI's President and CEO. "In addition to raising new capital, resulting in a strong cash position, and making our NASDAQ debut, it marked a period of focused progress across our two vaccine platforms. Our lead candidate, an innovative eVLP-based CMV vaccine, VBI-1501A, has progressed in line with our target milestones. Over the next twelve months, we plan to prepare several batches of VBI-1501A for toxicology studies and for our Phase I clinical trial, which is scheduled to start in Q4 2015."

VBI is developing a prophylactic vaccine to prevent Cytomegalovirus (CMV) infection . CMV is a leading cause of prenatal developmental delays. Based on strong preclinical data, VBI has initiated work for GMP manufacturing of its lead candidate for use in formal preclinical and Phase I trials. Phase I data is expected in 2016, at which time VBI expects to demonstrate safety, tolerability, and also immunological proof of concept in humans.

Third Quarter Highlights

  • Completed initial listing on NASDAQ.
  • Consummated two equity private placements for gross proceeds of $16.25M.
  • Obtained a senior secured term loan facility for up to $6M, of which VBI was able to draw down $3M in the third quarter.
  • Developed and scaled-up methods for the manufacture and purification of VBI-1501A with GMP sub-contractors.
  • Engaged regulatory advisors and continued preparation of documents supporting the IND filing of VBI-1501A.

About VBI Vaccines, Inc.

VBI Vaccines, Inc. ("VBI") is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the design of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus. VBI's lead eVLP asset is a prophylactic Cytomegalovirus ("CMV") vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. VBI's second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.

Website Home: http://www.vbivaccines.com

News and Insights: http://www.vbivaccines.com/wire/

Investors: http://ir.vbivaccines.com/

Forward-Looking Statement Disclosure

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the efficacy of potential products, the timelines for bringing such products to market, and the availability of funding sources for continued development of such products. Forward-looking statements are based on management's estimates, assumptions, and projections, and are subject to uncertainties, many of which are beyond the control of VBI. Actual results may differ materially from those anticipated in any forward-looking statement. Factors that may cause such differences include the risks that potential products that appear promising to VBI cannot be shown to be efficacious or safe in subsequent preclinical or clinical trials, VBI will not obtain appropriate or necessary governmental approvals to market these or other potential products, VBI may not be able to obtain anticipated funding for its development projects or other needed funding, and VBI may not be able to secure or enforce adequate legal protection, including patent protection, for its products. All forward-looking statements included in this press release are made only as of the date of this press release, and VBI does not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

More detailed information about VBI and risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in VBI's filings with the Securities and Exchange Commission (the "Commission"). VBI urges investors and security holders to read those documents free of charge at the Commission's Web site at http://www.sec.gov . Interested parties may also obtain those documents free of charge from VBI. Forward-looking statements speak only as to the date they are made, and except for any obligation under the U.S. federal securities laws, VBI undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.

Company Contact Jeff Baxter, President and CEO Phone: (617) 830-3031 x125 Email: Investor Contacts Robert B. Prag, President The Del Mar Consulting Group, Inc. Phone: (858) 361-1786 Email: Scott Wilfong, President Alex Partners, LLC Phone: (425) 242-0891 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 145

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 41

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 46

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 91

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 95

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 125

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 73

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 22

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 38

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
/section>

Top 5 Most Recently Viewed Articles

Unveiling Groundbreaking Research on Cenobamate at AES 2025

Updated Category News Views 163

Exciting New Developments in Epilepsy Treatment SK Life Science, Inc., a leading player in central nervous system (CNS) disorder treatments and a subsidiary of SK Biopharmaceuticals Co., Ltd., is ready to unveil ten posters featuring new research on cenobamate at the upcoming American Epilepsy Society (AES) Annual Meeting. This prestigious event will take place in...

Continue Reading
Teck Resources Unveils Strong First Quarter Earnings for 2025

Updated Category News Views 384

Teck Resources Limited Reports Impressive First Quarter Results Teck Resources Limited (NYSE: TECK, TSX: TECK.A, TSX: TECK.B) has announced its unaudited financial results for the first quarter of 2025, showcasing significant improvements over previous years. This marks a period of enhanced profitability driven by favorable market conditions. Financial Performance...

Continue Reading
Understanding Your Rights in the Symbotic Class Action

Updated Category News Views 155

Taking Action: Your Rights as an Investor in Symbotic Inc. Investors of Symbotic Inc. should be aware of a class action lawsuit initiated on their behalf. The law firm Kirby McInerney LLP is advocating for those who acquired Symbotic securities during the noted class period. This comes as a crucial reminder for shareholders to stay informed and consider their rights in...

Continue Reading
Scott Kelly Joins Worthington Steel Board, Boosting Strategy

Updated Category News Views 431

Scott Kelly Named to Worthington Steel Board Worthington Steel, Inc. (NYSE:WS), a prominent player in the metals processing industry, has officially welcomed Scott Kelly to its board of directors. This strategic appointment comes at a significant time as the company navigates its market challenges, including a recent 10% dip in stock price. Despite this, Worthington...

Continue Reading
Treasury Securities Agreements: A New Era for Primary Dealers

Updated Category News Views 232

Understanding the Latest Developments in Treasury Securities In a significant move to fortify the issuance and market making in Treasury securities, the Government Debt Management, on behalf of the Treasury, has signed crucial agreements with primary dealers. This initiative aims to ensure the Treasury’s uninterrupted access to financing while enhancing price formation...

Continue Reading